Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
2
×
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
2
×
deals
detroit blog main
detroit top stories
diagnostics
2
×
drug prices
gene therapy
generic drugs
gilead sciences
glaxosmithkline
immunotherapy
indiana blog main
indiana top stories
kaiser family foundation
life sciences
medicare
merck
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pembrolizumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
What
bio
drug
roundup
acquisitions
albert
approval
biggest
biogen’s
biopharmaceutical
bourla
ceo
companies
company
convo
crispr
earlier
failures
future
imports
littered
maker
maps
measured
nash
new
news
patients
pfizer
pfizer’s
price
remains
revenue
road
strategy
talk
today
world’s
Language
unknown
Current search:
diagnostics
×
" cancer immunotherapy "
×
" boston top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More